FDA-approved and commercially successful products are already providing clinically useful outcomes. Different approaches include (1) the use of engineered scaffolds, bioreactors and cell seeding techniques and (2) design and engineering of biomaterials that induce specific biological responses; this session seeks to review the science and business accomplishments—and prospects—of this emerging technology.



Objectives:

Review the science and business accomplishments of regenerative medicine, especially of cell-based therapies.

Describe the achievements and challenges for materials science.

Discuss the prospects for regenerative technologies and their capacity to change clinical medicine and life quality.